Its a miserable day today30 Mar 2018 13:42
SO................I revisited the final results for 2017 to re acquaint myself with my investment here. We do have ove �3M which will see us through until the end of the year and as I see it the company intends to increase its R&D this year but was not expecting an offsetting increase in revenue. The recent commercial contract has no value attributed to it revenue wise so i will assume that it is not a significant contributor to revenue. If it does though then good news.
As for the latest RNS it stated that:-
The Agreement covers the integration of Microsaic's compact 4500 MiD(R) mass spectrometry detector with Unimicro's Capillary Electrophoresis ("CE") Platform. Once integrated, the combined product will be sold directly by Unimicro in China via its extensive distribution network.
So for me I would like to know will this integration take place this year and is it likely that this will increase our revenue stream this year. If not then funds will need to be raised in Q3 2018!!